MyHealthChecked PLC Notice of Results (6139U)
March 29 2023 - 4:00AM
UK Regulatory
TIDMMHC
RNS Number : 6139U
MyHealthChecked PLC
29 March 2023
MyHealthChecked PLC
( " MyHealthChecked " or the "Company " )
Notice of Results
MyHealthChecked PLC (AIM: MHC), the consumer home-testing
healthcare company, will announce its preliminary results for the
year ended 31 December 2022 on Monday 3 April 2023.
Investor presentation
Penny McCormick, Chief Executive Officer and Nicholas Edwards,
Chief Financial Officer will provide a live presentation relating
to the preliminary results via the Investor Meet Company platform
on Monday 3 April at 4.30pm BST.
The presentation is open to all existing and potential
shareholders. Questions can be submitted pre-event via the Investor
Meet Company dashboard up until 9:00am BST the day before the
meeting or at any time during the live presentation. Investors can
sign up to Investor Meet Company for free and add to meet
MyHealthChecked PLC via:
https://www.investormeetcompany.com/myhealthchecked-plc/register-investor
Investors who already follow MyHealthChecked Plc on the Investor
Meet Company platform will automatically be invited.
For further information contact:
MyHealthChecked PLC www.myhealthchecked.com
Penny McCormick, Chief Executive via Walbrook PR
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Dowgate Capital Limited (Broker) Tel: +44 (0)20 3903 7715
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
& IR)
Paul McManus / Alice Woodings Mob: +44 (0)7980 541 893 / +44
(0)7407 804 654
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA
and RNA tests that have been developed following the acquisition of
The Genome Store in November 2020. The tests are available online,
and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORGIGDXCGDDGXC
(END) Dow Jones Newswires
March 29, 2023 05:00 ET (09:00 GMT)
Concepta (LSE:CPT)
Historical Stock Chart
From Oct 2024 to Nov 2024
Concepta (LSE:CPT)
Historical Stock Chart
From Nov 2023 to Nov 2024